what are the Recommendations for Patients at Risk for HF (Stage A: Primary
Prevention)
Referenced studies that support the recommendations are
summarized in the Online Data Supplements.?
For patients at risk of developing HF, natriuretic peptide biomarker?based screening followed by team-based care, including a cardiovascular specialist optimizing GDMT, can be useful to prevent the development of LV dysfunction (systolic or diastolic) or new-onset HF.